Back to results
US 11,718,642 B2Granted
Compositions and methods for treating CNS disorders
AssigneeSage Therapeutics, Inc.
InventorsAlbert Jean Robichaud, Francesco G. Salituro, Maria Jesus Blanco-Pillado, Daniel La, Boyd L. Harrison
Life of this patent
Estimating the term…
Abstract
Provided herein is a compound of Formula (I-I), or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I-I), and methods of using the compounds, e.g. in the treatment of CNS-related disorders.
Claims13
A compound of Formula (II-IIwa), (II-IIwb), or (II-IIwc)
- or a pharmaceutically acceptable salt thereof, wherein
- m is 0, 1, 2, or 3;
- p is 0, 1, or 2;
- and
- each R32 is independently halogen, C1-6 alkyl, hydroxyl, or cyano.
2 more elements
A compound selected from
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.